LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 321 of 520
Next
>>
>
8001 to 8025 of 12982 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
BT-20	Foretinib	0.12	uM	LJP5	2	H11	72	hr	1334	2783	4051	0.6870	0.5821
BT-20	Foretinib	0.12	uM	LJP5	3	H11	72	hr	1334	3005	4117	0.7298	0.6476
BT-20	Foretinib	0.37	uM	LJP5	1	H10	72	hr	1334	1385	3930	0.3524	0.0240
BT-20	Foretinib	0.37	uM	LJP5	2	H10	72	hr	1334	1392	4051	0.3436	0.0266
BT-20	Foretinib	0.37	uM	LJP5	3	H10	72	hr	1334	1328	4117	0.3225	-0.0031
BT-20	Foretinib	1.11	uM	LJP5	1	H09	72	hr	1334	1057	3930	0.2689	-0.1390
BT-20	Foretinib	1.11	uM	LJP5	2	H09	72	hr	1334	1053	4051	0.2599	-0.1376
BT-20	Foretinib	1.11	uM	LJP5	3	H09	72	hr	1334	985	4117	0.2392	-0.1705
BT-20	Foretinib	3.33	uM	LJP5	1	H08	72	hr	1334	1070	3930	0.2722	-0.1322
BT-20	Foretinib	3.33	uM	LJP5	2	H08	72	hr	1334	1021	4051	0.2520	-0.1540
BT-20	Foretinib	3.33	uM	LJP5	3	H08	72	hr	1334	1024	4117	0.2487	-0.1504
BT-20	Foretinib	10	uM	LJP5	1	H07	72	hr	1334	787	3930	0.2002	-0.2875
BT-20	Foretinib	10	uM	LJP5	2	H07	72	hr	1334	806	4051	0.1990	-0.2701
BT-20	Foretinib	10	uM	LJP5	3	H07	72	hr	1334	869	4117	0.2110	-0.2320
BT-20	AZD 5438	0.04	uM	LJP6	1	J06	72	hr	1334	3995	3955	1.0099	1.0126
BT-20	AZD 5438	0.04	uM	LJP6	2	J06	72	hr	1334	3829	3899	0.9820	0.9767
BT-20	AZD 5438	0.04	uM	LJP6	3	J06	72	hr	1334	3422	3921	0.8727	0.8323
BT-20	AZD 5438	0.12	uM	LJP6	1	J05	72	hr	1334	3469	3955	0.8769	0.8393
BT-20	AZD 5438	0.12	uM	LJP6	2	J05	72	hr	1334	3342	3899	0.8571	0.8102
BT-20	AZD 5438	0.12	uM	LJP6	3	J05	72	hr	1334	3158	3921	0.8053	0.7400
BT-20	AZD 5438	0.37	uM	LJP6	1	J04	72	hr	1334	2818	3955	0.7124	0.6109
BT-20	AZD 5438	0.37	uM	LJP6	2	J04	72	hr	1334	2684	3899	0.6884	0.5710
BT-20	AZD 5438	0.37	uM	LJP6	3	J04	72	hr	1334	2628	3921	0.6702	0.5461
BT-20	AZD 5438	1.11	uM	LJP6	1	J03	72	hr	1334	1947	3955	0.4922	0.2724
BT-20	AZD 5438	1.11	uM	LJP6	2	J03	72	hr	1334	1701	3899	0.4363	0.1698

|<
<<
Previous
Page 321 of 520
Next
>>
>
8001 to 8025 of 12982 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)